The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.
| Pre-meeting symposia | ||||
|---|---|---|---|---|
| 14:30 – 15:00 | Clinical Application of Amino Acid-based Dialysis Solution | |||
| 15:00 – 15:30 | Central Mechanisms of Kappa Opioids in Itch Control | |||
| 15:30 – 16:00 | Decoding Pruritus, Achieving Comprehensive Benefits | |||
| Welcome and Opening Session Session moderators: Liz Lightstone, UK | Guang-yan Cai, China | Hongli Lin, China |
||||
| 17:00 – 17:06 | Opening Address from the ISN – Liz Lightstone, UK | |||
| 17:06 – 17:09 | Welcome Address from the CSN and ISN Frontiers Co-chair – Guang-yan Cai, China | |||
| 17:09 – 17:12 | Welcome Address from the CSN – Xiaoqiang Ding, China | |||
| 17:12 – 17:14 | Welcome from Dalian Medical University – Ying Liu , China | |||
| 17:14 – 17:16 | Welcome from Dalian Medical University – Hongli Lin, China | |||
| 17:18 – 17:21 | Welcome and Opening Remarks by ISN Frontiers Co-chair – Masaomi Nangaku, Japan | |||
| 17:21 – 17:24 | Welcome and Opening Remarks by ISN Frontiers Co-chair – Sola Aoun Bahous, Lebanon | |||
| 17:25 – 18:05 | Building AI Knowledge for Nephrology Practice – Sola Aoun Bahous, Lebanon | |||
| 18:05 – 18:45 | Why Kidney Registries Matter – Fergus Caskey, UK | |||
| Welcome & Networking Reception (18:45 – 20:00) | ||||
| Session 2: Keynote
Session moderator: Liz Lightstone, UK |
||
|---|---|---|
| 09:00 – 09:40 | MRAs for Cardio-Kidney-Metabolic Health – Peter Rossing, Denmark | |
| Coffee Break and Poster Viewing (09:40 – 10:10) | ||
| Session 3: Rare Kidney Diseases: From Mechanisms to Implementation
Session moderators: Masaomi Nangaku, Japan | Meg Jardine, Australia |
||
| 10:10 – 10:35 | Endothelin A Receptor Antagonists in IgA Nephropathy – Meg Jardine, Australia | |
| 10:35 – 11:00 | How Complement Pathways Drive IgA Nephropathy – Sung Gyun Kim, South Korea | |
| 11:00 – 11:25 | B cell-targeted therapies for IgA nephropathy – Sydney Tang, Hong Kong, China | |
| Industry symposia (Lunch will be served in the room only) |
||
| 11:35 – 12:35 | Ushering in a New Curative Era for IgAN – From Pathogenesis to Precision Targeting | |
| 12:40 – 13:10 | 2026 Hot Topics in Chronic Kidney Disease and Hyperkalemia | |
| Session 4: Innovations in AKI: From Lab to Clinic
Session moderators: Motoko Yanagita, Japan | Minghui Zhao, China |
||
| 13:15 – 13:40 | Linking Molecular Pathways to AKI Outcomes – Motoko Yanagita, Japan | |
| 13:40 – 14:05 | Can AI Detect AKI Early? – Sejoong Kim, South Korea | |
| 14:05 – 14:30 | Protecting Kidneys in Cardiac Surgery: The RIPC Approach – Xiaoqiang Ding, China | |
| 14:30 – 14:55 | Stem Cell Therapy for AKI: From Bench to Bedside – Guang-yan Cai, China | |
| Coffee Break and Poster Viewing (14:55 – 15:25) | ||
| Session 5: Implementing Cardio-Kidney-Metabolic Care: From Mechanisms to Global Burden
Session moderators: Sunita Bavanandan, Malaysia | Guang-yan Cai, China |
||
| 15:25 – 15:50 | Molecular Mechanisms of Cardio-Kidney-Metabolic Syndrome – Jin Joo Cha, South Korea | |
| 15:50 – 16:15 | Burden of Cardio-Kidney-Metabolic Syndrome in Asia – Sunita Bavanandan, Malaysia | |
| 16:15 – 16:40 | Cardio-Kidney-Metabolic Syndrome: An Integrated Approach to the Global Health Burden – Pringgodigdo Nugroho, Indonesia | |
| 16:40 – 17:05 | The role of the ISN in implementation of cardiovascular-kidney-metabolic care – Adeera Levin, Canada | |
| Industry Symposium | ||
| 17:05 – 18:05 | Non-steroidal MRAs: Redefining Care in CKM | |
| Networking Dinner (18:10 – 20:00) | ||
| Session 6: Keynote Session moderator: Fergus Caskey, UK |
||
|---|---|---|
| 08:30 – 09:10 | Telemedicine and AI for Smarter Nephrology Practice – Masaomi Nangaku, Japan | |
| Session 7: Application of Artificial Intelligence and Digital Transformation in Kidney Care Session moderators: Sola Aoun Bahous, Lebanon | Xiaoqiang Ding, China |
||
| 09:15 – 09:30 | AI and Kidney Disease – Lu-Xia Zhang, China | |
| 09:30 – 09:45 | AI in Transplantation Pathology – Alton B Farris, USA | |
| 09:45 – 10:00 | Multi-Stain Deep Learning Model to Predict Treatment Response in Lupus Nephritis – Wei Chen, China | |
| 10:00 – 10:15 | Unveiling Kidney Disease Through Body Gas Sensing Techniques – Yosuke Hirakawa, Japan | |
| Coffee Break and Poster Viewing (10:15 – 10:45) | ||
| Session 8: Innovations in Blood Purification for Kidney Disease Session moderators: Kornchanok Vareesangthip, Thailand | Bicheng Liu, China |
||
| 10:45 – 11:10 | Glycation End Products and Kidney Disease – Kornchanok Vareesangthip, Thailand | |
| 11:10 – 11:35 | Peritoneal Dialysis: Advances and Challenges – Winston Fung, Hong Kong, China | |
| 11:35 – 12:00 | HIF Inhibitors: Transforming Anaemia Care – Ping Li, China | |
| 12:00 – 12:25 | Novel Blood Purification Approaches in Kidney Care – Hong-Li Lin, China | |
| 12:25 – 12:40 | Abstract Oral Presentation – Yuhang Ma, China : Machine Learning–Based Short-Term Prognostic Models for IgA Nephropathy: A Multicenter Development and Validation Study |
|
| Industry symposia (Lunch will be served in the room only) |
||
| 12:50 – 13:20 | Non-steroidal MRAs: Reshaping CKD Care Landscape | |
| 13:25 – 13:55 | Advances in the Diagnosis and Treatment of Membranous Nephropathy | |
| Session 9: Research and Trials Driving Advances in Rare Kidney Diseases Session moderators: Sydney Tang, Hong Kong, China | Chun Zhang, China |
||
| 14:10 – 14:35 | Rare Kidney Diseases from a Patient Perspective – Bill Wang, Hong Kong, China | |
| 14:35 – 15:00 | Rare Kidney Diseases in China: Challenges and Progress – Li-Meng Chen, China | |
| 15:00 – 15:25 | Managing Kidney Involvement in Lupus – Liz Lightstone, UK | |
| 15:25 – 15:50 | Improving Outcomes for Children With Rare Kidney Disease – Hong Xu, China | |
| 15:50 – 16:05 | Abstract Oral Presentation – Jia Chen, China: Targeted intervention for DcR2 alleviates acute kidney injury by modulating tubular senescence |
|
| Young Nephrologist Award Ceremony (16:05 – 16:10) | ||
| Coffee Break and Poster Viewing (16:10 – 16:40) | ||
| Session 10: Advances in CKM Care and Closing Remarks Session moderators: Guang-yan Cai, China | Sola Aoun Bahous, Lebanon | Masaomi Nangaku, Japan |
||
| 16:40 – 17:05 | Integrating GLP-1RA Into Cardio-Kidney-Metabolic Management – Sydney Tang, Hong Kong, China | |
| 17:05 – 17:30 | SGLT2i for CKD: Expanding Benefits Beyond Diabetes – Xiao-Xi Zeng, China | |
| 17:30 – 17:45 | Abstract Oral Presentation – Li Zhu, China: Carnitine Acetyltransferase Attenuates Chronic Kidney Disease-Related Cardiomyopathy via STAT3-Regulated Mitochondrial Dysfunction and Cardiomyocyte Hypertrophy |
|
| 17:45 – 18:05 | Reflections and Closing Remarks From the ISN Frontiers Co-chairs – Sola Aoun Bahous, Lebanon | Guang-yan Cai, China | Masaomi Nangaku, Japan | |